Microspheres for active embolization
    53.
    发明授权
    Microspheres for active embolization 有权
    活性栓塞微球

    公开(公告)号:US08741351B2

    公开(公告)日:2014-06-03

    申请号:US13371964

    申请日:2012-02-13

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地输送用于栓塞药物治疗的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于治疗血管生成和非血管生成依赖性疾病的方法。

    MICROSPHERES FOR ACTIVE EMBOLIZATION
    54.
    发明申请
    MICROSPHERES FOR ACTIVE EMBOLIZATION 有权
    用于主动嵌入的微结构

    公开(公告)号:US20120213831A1

    公开(公告)日:2012-08-23

    申请号:US13462004

    申请日:2012-05-02

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地输送用于栓塞药物治疗的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于治疗血管生成和非血管生成依赖性疾病的方法。

    Injectable and swellable microspheres for dermal augmentation
    55.
    发明授权
    Injectable and swellable microspheres for dermal augmentation 有权
    可注射和可溶胀的微球用于皮肤增强

    公开(公告)号:US08142815B2

    公开(公告)日:2012-03-27

    申请号:US10919257

    申请日:2004-08-17

    CPC classification number: A61L27/52 A61L27/26 C08L33/26

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, hydrophilic, non-toxic and substantially spherical microspheres microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further relates to methods of dermal augmentation, particularly for the treatment of skin contour deficiencies, using the injectable compositions.

    Abstract translation: 本发明涉及可注射组合物,其包含生物相容性,可溶胀,亲水,无毒和基本上为球形的微球微球和用于皮肤增生的生物相容性载体。 本发明还涉及使用可注射组合物的皮肤增强方法,特别是用于治疗皮肤轮廓缺陷的方法。

    Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same
    56.
    发明授权
    Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same 有权
    聚乙烯醇微球,注射液和治疗用途相同

    公开(公告)号:US07670592B2

    公开(公告)日:2010-03-02

    申请号:US12348867

    申请日:2009-01-05

    Inventor: Egisto Boschetti

    CPC classification number: A61K9/1635 A61K47/6927

    Abstract: The present invention relates to microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable liquid carrier. The present invention further relates to a method for prophylactic or therapeutic embolization which comprises administering to a mammal an injectable suspension containing the polyvinylalcohol microspheres and a suitable liquid carrier. Finally, the present invention relates to a process for producing the polyvinylalcohol microspheres.

    Abstract translation: 本发明涉及包含聚乙烯醇的栓塞用微球。 本发明还涉及适用于栓塞的可注射悬浮液,其包含聚乙烯醇微球和合适的液体载体。 本发明还涉及一种用于预防或治疗性栓塞的方法,其包括向哺乳动物施用含有聚乙烯醇微球和适合的液体载体的可注射悬浮液。 最后,本发明涉及聚乙烯醇微球的制造方法。

    Polyvinyl alcohol microspheres, and injectable solutions of the same
    57.
    发明授权
    Polyvinyl alcohol microspheres, and injectable solutions of the same 有权
    聚乙烯醇微球,以及其注射溶液

    公开(公告)号:US07591993B2

    公开(公告)日:2009-09-22

    申请号:US10692785

    申请日:2003-10-27

    Inventor: Egisto Boschetti

    CPC classification number: A61K9/1635 A61K47/6927

    Abstract: The present invention relates to microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable liquid carrier. The present invention further relates to a method for prophylactic or therapeutic embolization which comprises administering to a mammal an injectable suspension containing the polyvinylalcohol microspheres and a suitable liquid carrier. Finally, the present invention relates to a process for producing the polyvinylalcohol microspheres.

    Abstract translation: 本发明涉及包含聚乙烯醇的栓塞用微球。 本发明还涉及适用于栓塞的可注射悬浮液,其包含聚乙烯醇微球和合适的液体载体。 本发明还涉及一种用于预防或治疗性栓塞的方法,其包括向哺乳动物施用含有聚乙烯醇微球和适合的液体载体的可注射悬浮液。 最后,本发明涉及聚乙烯醇微球的制造方法。

    MICROSPHERES FOR ACTIVE EMBOLIZATION
    59.
    发明申请
    MICROSPHERES FOR ACTIVE EMBOLIZATION 审中-公开
    用于主动嵌入的微结构

    公开(公告)号:US20080220077A1

    公开(公告)日:2008-09-11

    申请号:US12122590

    申请日:2008-05-16

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地输送用于栓塞药物治疗的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于治疗血管生成和非血管生成依赖性疾病的方法。

Patent Agency Ranking